Related Experiment Video
Updated: Feb 9, 2026

Measuring Erythrocyte Complement Receptor 1 Using Flow Cytometry
Published on: May 19, 2020
Erythrocyte-bound C4d in combination with complement and autoantibody status for the monitoring of SLE
Joan T Merrill1, Michelle A Petri2, Jill Buyon3
1Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.
Insights
Erythrocyte-bound C4d (EC4d) effectively monitors Systemic Lupus Erythematosus (SLE) disease activity, showing significant associations with clinical assessments regardless of complement levels. This biomarker aids in tracking SLE progression and treatment response.
Area of Science:
- Immunology
- Rheumatology
- Clinical Chemistry
Background:
- Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease requiring reliable monitoring of disease activity.
- Current monitoring methods may not fully capture disease fluctuations.
- Erythrocyte-bound C4d (EC4d) is a potential biomarker for immune complex deposition in SLE.
Purpose of the Study:
- To evaluate the utility of EC4d as a biomarker for monitoring SLE disease activity.
- To determine the association between EC4d levels and established clinical disease activity indices.
Main Methods:
- Longitudinal data from 124 SLE patients across three studies were analyzed.
- Disease activity was assessed using the Physicians Global Assessment (PGA) and clinical SELENA-SLEDAI.
- EC4d levels were measured via flow cytometry; complement C3/C4 and anti-dsDNA antibodies were also quantified.
Main Results:
- EC4d levels were significantly associated with both PGA and clinical SELENA-SLEDAI across all study groups (p<0.05).
- Multivariate analysis confirmed EC4d as an independent predictor of disease activity (p<0.01).
- Associations remained significant even in patients with normal or chronically low complement C3/C4 levels.
Conclusions:
- EC4d demonstrates significant association with SLE disease activity, independent of complement C3/C4 status.
- EC4d is a promising biomarker for monitoring SLE disease activity.
- Further validation studies are warranted to support these findings.
Background:
We examined the usefulness of erythrocyte-bound C4d (EC4d) to monitor disease activity in SLE.
Methods:
Data and blood samples were collected from three different studies, each of which included longitudinal evaluations using the Physicians Global Assessment (PGA) of disease activity and the Safety of Estrogens in Lupus Erythematosus National Assessment (SELENA) SLE Disease Activity Index (SLEDAI), which was assessed without anti-double-stranded DNA (dsDNA) and low complement C3/C4 (clinical SELENA-SLEDAI). EC4d levels were determined using flow cytometry; other laboratory measures included antibodies to dsDNA, C3 and C4 proteins. Relationships between clinical SELENA-SLEDAI, PGA and the laboratory measures were analysed using linear mixed effect models.
Results:
The three studies combined enrolled 124 patients with SLE (mean age 42 years, 97% women, 31% Caucasians and 34% African-Americans) followed for an average of 5 consecutive visits (range 2-13 visits). EC4d levels and low C3/C4 status were significantly associated the clinical SELENA-SLEDAI or PGA in each of the three study groups (p<0.05). Multivariate analysis revealed that EC4d levels (estimate=0.94±0.28) and low complement C3/C4 (estimate=1.24±0.43) were both independently and significantly associated with the clinical SELENA-SLEDAI (p<0.01) and PGA. EC4d levels were also associated with the clinical SELENA-SLEDAI (estimate: 1.20±0.29) and PGA (estimate=0.19±0.04) among patients with chronically low or normal C3/C4 (p<0.01). Anti-dsDNA titres were generally associated with disease activity.
Conclusion:
These data support the association of EC4d with disease activity regardless of complement C3/C4 status and its usefulness in monitoring SLE disease. Additional studies will be required to support these validation data.
Related Concept Videos
Complement System
Complementation Tests
Organisms heterozygous for different mutations are crossed pairwise in all combinations. If present on different genes, the mutations can complement each other by providing the missing...
Lifecycle of Erythrocytes
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups....
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Structure and Function of Erythrocytes
The erythrocyte plasma membrane is associated with proteins such as spectrin, which forms a flexible cytoplasmic meshwork. This meshwork allows erythrocytes to twist, turn, become cup-shaped, and regain their biconcave shape as they pass through narrow capillaries. Additionally, erythrocytes can form...
Marcia's Theory of Identity Status

